Olivier Chesnoy

Technoflex SAS engages in the design, manufacture, and marketing of flexible containers for pharmaceutical industry. Its therapeutic applications include IV therapies, cell therapy, and biopharmaceuticals. The company's products include sterile bags, multi-chamber bags, and connectors. It also provides turnkey solutions and generic drug dossiers. The company was founded by Jacques Ponlot in 1972 and is headquartered in Bidart, France.

Theraptosis S.A. , a biotechnology company, was founded in April 2001. Theraptosis designs and develops various drugs that act on key apoptosis regulators to fight diseases associated with lack or excess of apoptosis including cancer and neurodegenerative diseases. The Company's key assets include a dual technology platform (CytoTrust™ and MitoTrust™) for screening and targeting purposes and a pipeline of products in the areas of CNS and oncology. Theraptosis' discovery engines integrate mitochondria, and apoptosis expertise, and has developed pre-clinical animal models.